Press release
Mumps Vaccine (MumpsVax) Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers
Mumps Vaccine MumpsVax
The amplified incidence of infectious diseases is anticipated to spur the growth of the mumpsvax market. Pathogenic microorganisms like viruses, bacteria, fungi or parasites cause infectious diseases, which can transmit from person to person or through a contaminated environment. The spread of these diseases is influenced by factors like urbanization, climate change, globalization, changes in human demographics and behavior, triggering the propagation and emergence of pathogens. Mumpsvax, a mumps vaccine, is primarily utilized to prevent infection caused by the mumps virus, often part of the MMR (measles, mumps, rubella) vaccination. For example, in August 2024, a report issued by the UK Health Security Agency reported that West Midlands reported the highest number of measles cases (160 cases, 44%), followed by London with 122 cases (33%). Children below 10 years constituted 63% of the total cases, 232 in number. The end of the year saw an upward trajectory with 157 new cases in December, a spike from 45 cases in November. Heightened healthcare expenditure is projected to catalyze the growth of the mumpsvax market. Healthcare expenditure constitutes the aggregate amount allocated to health care products and services, including personal health care, preventative services, and public health activities. This expenditure is ascending, influenced by factors like an aging population, chronic diseases, advanced medical technology, high medication prices, inefficient payment models and higher demand for services. A surge in healthcare expenditure echoes on the mumpsvax market by augmenting funding for vaccination campaigns, improving accessibility of the vaccine that enhances public health outcomes via increased immunization rates against mumps.
Get Your Mumps Vaccine (MumpsVax) Market Report Here:
https://www.thebusinessresearchcompany.com/report/mumps-vaccine-mumpsvax-global-market-report
How will the growth rate of the mumps vaccine (mumpsvax) market shape industry trends by 2034?
The market for the mumps vaccine (mumpsvax) has seen substantial growth recently. The market size is projected to surge from $2,057.93 million in 2024 to $2,210.59 million in 2025, reflecting a compound annual growth rate (CAGR) of 7.4%. The ascent during the historical phase is credited to an uptick in childhood vaccination rates, a surge in global health campaigns, rising public faith in vaccines, enhanced travel consciousness, and amplified immunization drives.
A significant expansion is predicted in the mumps vaccine (mumpsvax) market in the coming years, with its size likely to reach $2,902.21 million in 2029, experiencing a 7.0% compound annual growth rate (CAGR). The anticipated growth during this period can be connected to the increased prevalence of diseases that can be avoided through vaccination, enhanced awareness about adult immunization, escalating health mindfulness, the rise in immunization agendas, and additional global health drives. The forecast period is set to witness major developments such as bespoke vaccination methodologies, incorporation of digital health, improved observation systems, research and development in adult immunization, and the adoption of artificial intelligence.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19909&type=smp
Which primary segments of the mumps vaccine (mumpsvax) market are driving growth and industry transformations?
The mumps vaccine (mumpsvax)market covered in this report is segmented -
1) By Product Type: Monovalent; Combinational; Divalent; Trivalent; Other Product Types
2) By Age Group: Pediatric; Adult
3) By Distribution Channels: Hospital pharmacies; Drug Stores; Retail Pharmacies
4) By End-User: Pediatric Clinic; Hospitals; Non-Governmental Organization (NGOs); Other End-Users
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/Discount?id=19909&type=discount
Which geographical regions are pioneering growth in the mumps vaccine (mumpsvax) market?
North America was the largest region in the mumps vaccine (mumpsvax) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mumps vaccine (mumpsvax) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the influential players reshaping the mumps vaccine (mumpsvax) market landscape?
Major companies operating in the mumps vaccine (mumpsvax) market include Merck & Co. Inc., GlaxoSmithKline plc
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=19909&type=smp
What Is Covered In The Mumps Vaccine (MumpsVax) Global Market Report?
•Market Size Forecast: Examine the mumps vaccine (mumpsvax) market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the mumps vaccine (mumpsvax) market for a structured understanding.
•Key Players Overview: Analyze major players in the mumps vaccine (mumpsvax) market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the mumps vaccine (mumpsvax) market.
•Segment Contributions: Evaluate how different segments drive overall growth in the mumps vaccine (mumpsvax) market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the mumps vaccine (mumpsvax) market.
•Industry Challenges: Identify potential risks and obstacles affecting the mumps vaccine (mumpsvax) market.
•Competitive Landscape: Review strategic developments in the mumps vaccine (mumpsvax) market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Mumps Vaccine (MumpsVax) Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers here
News-ID: 3937543 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Mumps
Global Measles Mumps And Rubella Mmr Vaccines Market Size by Application, Type, …
USA, New Jersey- According to Market Research Intellect, the global Measles Mumps And Rubella Mmr Vaccines market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The market for measles, mumps, and rubella (MMR) vaccines is steadily expanding as a result of growing vaccination campaigns and greater…
Mumps Vaccine Market Expected to Reach $3.5 Billion by 2031
Mumps vaccine is the most efficient way of preventing mumps viral infection in children and elderly population. Mumps vaccine is mainly administered in the form of combination vaccine, which offers resistance against measles, mumps, and rubella virus infections. The vaccine has no side effects; however, some cases may encounter very mild fever or rash. In addition, in some pediatric patients, mumps vaccine is given in the form of MMRV vaccine,…
Mumps Vaccine Market Analysis Growth Opportunities and Trends by Forecast To 203 …
Mumps Vaccine Market - Overview
Mumps is an infectious viral disease that results in swelling of the parotid salivary glands of the face. It is contagious and therefore, runs at a high risk of sterility when occurs in adult males. Mumps is usually characterized by muscle aches, headache, tiredness and fever, loss of appetite, and typical swelling of the one or more salivary glands.
Some other complications of mumps include infection in…
Mumps Vaccine Market Boosting Technologies, Industry Growth, Demand Status, Tren …
Measles, Mumps, and Rubella (MMR) vaccinations are a mixture of live viruses that are injected. The live viruses are inactivate and cannot reproduce in human cells while the immune system responds and defends against the infection. The MMR vaccine has a long-term effect. The MMR vaccine causes fever, rash, cough, body pain, headache, nausea and severe consequences such as ovaries and testicles infection, deafness, and in rare cases it leads…
Measles, Mumps and Rubella (MMR) Vaccines Market Opportunity Analysis, 2026 – …
Measles, mumps, and rubella are the three common contagious airborne diseases that are highly caused by virus transmitted by sneezing and coughing of the infected person, which could lead to serious complications or death among children. Vaccines of these diseases are sold as attenuated viral vaccines, manufactured in a lyophilised formulation, which requires reconstitution with water for injection diluent and are available in two forms i.e. monovalent as well as…
Mumps - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Mumps - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mumps - Pipeline Review, H1 2017, provides an overview of the Mumps (Infectious Disease) pipeline landscape.
Mumps is a contagious disease that leads to painful swelling of the salivary glands. The mumps are caused by a virus.…
